Former Vice President, Finance and interim Principal Accounting Officer · IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Michael Swartzburg

A named executive officer of IOVANCE BIOTHERAPEUTICS in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,314,008

Salary $65,321Stock awards $0Bonus $30,000

FY2020: $1,074,896

6th of 6 named executive officers at Iovance Biotherapeutics by FY2021 total.

6 named officers on file for IOVANCE BIOTHERAPEUTICS, FY2021

Michael Swartzburg’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • IOVA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IOVANCE BIOTHERAPEUTICS’s whole pay program stands against its peers

  • IOVANCE BIOTHERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IOVA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Michael Swartzburg’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Swartzburg compensation by year

IOVANCE BIOTHERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as IOVANCE BIOTHERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$305,208$65,321
Bonus$0$30,000
Stock awards$0$0
Option awards$707,767$1,211,360
Non-equity incentive$50,521$0
Pension and deferred compensation$0$0
All other$11,400$7,328
Total$1,074,896$1,314,008

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IOVANCE BIOTHERAPEUTICS, INC. DEF 14A filed April 27, 2022, accession 0001104659-22-051293, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IOVANCE BIOTHERAPEUTICS, INC. filed document, accession 0001104659-22-051293. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$1.1M
$1.3M
FY20
FY21
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option46,500—$23.88
Option14,657—$11.26
Option7,917—$19.50

Per the Outstanding Equity Awards at Fiscal Year-End table in IOVANCE BIOTHERAPEUTICS, INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

IOVANCE BIOTHERAPEUTICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Frederick VogtInterim President and Chief Executive Officer$7,927,153
Maria FardisFormer President and Chief Executive Officer$7,011,698
Igor BilinskyChief Operating Officer$4,524,421
Friedrich FinckensteinChief Medical Officer$4,281,044
Jean-Marc BelleminChief Financial Officer$1,523,499
Michael Swartzburg · this pageFormer Vice President, Finance and interim Principal Accounting Officer$1,314,008

The full IOVANCE BIOTHERAPEUTICS compensation record

free company brief

This page is one person within IOVANCE BIOTHERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IOVANCE BIOTHERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IOVANCE BIOTHERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Swartzburg's compensation dossier · One-time report. No refunds.